A scientist examines a sample with laboratory equipment in the office of Danish biosolutions company Novonesis in Beijing's Haidian district in 2025. CHINA DAILY
As Chinese pet owners increasingly demand science-backed nutrition rather than traditional pet food, global biotechnology suppliers are moving to tap into a domestic pet economy projected to grow significantly by 2028.
Danish biosolutions company Novonesis has made China a priority market for its new pet business unit launched in 2025.
The company, formed in 2024 through the merger of enzyme producer Novozymes and probiotic specialist Chr. Hansen, positions itself not as a pet food brand, but as an upstream biotechnology supplier, providing enzymes and microbial solutions for pet nutrition and health.
Its entry reflects a broader shift in China's fast-growing pet economy, where global pet firms are increasingly targeting the country not only as a consumer market, but also as a base for research, production and partnerships with local brands.
